- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Sionna Therapeutics (SION)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 51.79 mm | 51.79 mm | 51.79 mm | 51.79 mm | 51.79 mm | 51.79 mm |
| Cash burn (monthly) | (no burn) | 2.66 mm | 7.94 mm | 5.45 mm | (no burn) | 1.34 mm |
| Cash used (since last report) | n/a | 11.43 mm | 34.16 mm | 23.45 mm | n/a | 5.77 mm |
| Cash remaining | n/a | 40.36 mm | 17.63 mm | 28.34 mm | n/a | 46.02 mm |
| Runway (months of cash) | n/a | 15.2 | 2.2 | 5.2 | n/a | 34.3 |
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 26 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 44.58 | 29,063 | 1.30 mm | 3,530,702 |
| 3 Feb 26 | Thompson Peter A. | Common Stock | Sell | Dispose S | Yes | No | 44.58 | 29,063 | 1.30 mm | 3,530,702 |
| 2 Feb 26 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 44.57 | 1,890 | 84.24 k | 3,559,765 |
| 2 Feb 26 | Thompson Peter A. | Common Stock | Sell | Dispose S | Yes | No | 44.57 | 1,890 | 84.24 k | 3,559,765 |
| 22 Jan 26 | TPG GP A | Common Stock | Sell | Dispose S | Yes | No | 40 | 250,000 | 10.00 mm | 6,494,962 |
| 2 Jan 26 | Ridloff Elena | NQSO Common Stock | Grant | Acquire A | No | No | 39.21 | 165,440 | 6.49 mm | 165,440 |
| 2 Jan 26 | Caroline Stark Beer | NQSO Common Stock | Grant | Acquire A | No | No | 39.21 | 139,340 | 5.46 mm | 139,340 |